Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.
Tenet Healthcare's focus on high-acuity procedures like joint replacements and spinal fusions helped it grow earnings in Q3 2026, even as overall surgical volumes dipped. The health system raised its full-year guidance despite headwinds from the expiration of ACA premium subsidies, which drove up uninsured rates. Tenet now expects full-year net income of up to $3.08 billion on revenues of up to $22.5 billion.
Tenet Healthcare posted a strong Q3 2026 by doubling down on complex, high-value procedures — think joint replacements, advanced spinal fusions, and robotic-assisted urological surgeries — even as the broader surgical market softened. While competitors took earnings hits from declining procedure volumes, Tenet grew margins in both its hospital and ambulatory units, crediting its long-term pivot toward higher-acuity care.
A key driver was United Surgical Partners International (USPI), Tenet's ambulatory surgery arm and the largest ambulatory network in the U.S., with 535 ASCs across 37 states. USPI performed 12.8% more total joint replacements year-over-year in Q3, helping push its adjusted EBITDA up 9.1% to $537 million. The health system wasn't immune to broader pressures, though — the expiration of enhanced ACA premium tax credits has pushed more patients to go uninsured, with Tenet's exchange admissions and revenues both falling 18% year-over-year. A one-time boost from regaining full ownership of its revenue cycle subsidiary, Conifer Health, also helped lift results.
By the Numbers:
Why it matters: Tenet's results highlight a growing divide in hospital finances — systems that have invested in high-acuity outpatient care are better positioned to absorb payer-mix pressures, while those reliant on inpatient volume face steeper headwinds as ACA subsidy losses push more Americans to go uninsured.
